Johnson & Johnson announces binding offer from Platinum Equity to acquire LifeScan, Inc.
Johnson & Johnson announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for $2.1 billion. LifeScan, Inc. is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion. March 16, 2018